Phase 1 Study of Onapristone in Patients With Progesterone Receptor Expressing Cancers

This study is currently recruiting participants.
Verified January 2014 by Arno Therapeutics
Sponsor:
Information provided by (Responsible Party):
Arno Therapeutics
ClinicalTrials.gov Identifier:
NCT02052128
First received: January 28, 2014
Last updated: January 29, 2014
Last verified: January 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2015
  Estimated Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)